10.68
0.14 (1.33%)
| Previous Close | 10.54 |
| Open | 10.46 |
| Volume | 1,232,518 |
| Avg. Volume (3M) | 12,904,262 |
| Market Cap | 22,922,379,264 |
| Price / Sales | 2.87 |
| Price / Book | 2.42 |
| 52 Weeks Range | |
| Earnings Date | 7 Mar 2025 - 11 Mar 2025 |
| Profit Margin | -17.53% |
| Operating Margin (TTM) | -26.86% |
| Diluted EPS (TTM) | -0.650 |
| Quarterly Revenue Growth (YOY) | 43.50% |
| Total Debt/Equity (MRQ) | 54.23% |
| Current Ratio (MRQ) | 4.15 |
| Operating Cash Flow (TTM) | -19.89 M |
| Levered Free Cash Flow (TTM) | -250.39 M |
| Return on Assets (TTM) | -6.40% |
| Return on Equity (TTM) | -16.62% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (HK) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | GENSCRIPT BIO | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.0 |
| Average | -0.63 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| GENSCRIPT BIO | 23 B | - | - | 2.42 |
| OCUMENSION-B | 3 B | - | - | 1.17 |
| HBM HOLDINGS-B | 3 B | - | 17.00 | 2.77 |
| TOT BIOPHARM-B | 1 B | - | 190.00 | 1.70 |
| AKESO | 55 B | - | - | 9.50 |
| INNOVENT BIO | 53 B | - | - | 4.54 |
|
Genscript Biotech Corp is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 37.44% |
| % Held by Institutions | 22.27% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |